School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.
J Thromb Haemost. 2017 Sep;15(9):1818-1828. doi: 10.1111/jth.13773. Epub 2017 Aug 9.
Essentials Corn Trypsin Inhibitor (CTI) is a selective inhibitor of coagulation Factor XII (FXII). Molecular modelling of the CTI-FXIIa complex suggested a canonical inhibitor binding mode. Mutagenesis revealed the CTI inhibitory loop and helices α1 and α2 mediate the interaction. This confirms that CTI inhibits FXII in canonical fashion and validates the molecular model.
Background Corn trypsin inhibitor (CTI) has selectivity for the serine proteases coagulation factor XII and trypsin. CTI is in widespread use as a reagent that specifically inhibits the intrinsic pathway of blood coagulation but not the extrinsic pathway. Objectives To investigate the molecular basis of FXII inhibition by CTI. Methods We performed molecular docking of CTI, using its known crystal structure, with a model of the activated FXII (FXIIa) protease domain. The interaction model was verified by use of a panel of recombinant CTI variants tested for their ability to inhibit FXIIa enzymatic activity in a substrate cleavage assay. Results The docking predicted that: (i) the CTI central inhibitory loop P1 Arg34 side chain forms a salt bridge with the FXIIa S1 pocket Asp189 side chain; (ii) Trp22 from CTI helix α1 interacts with the FXIIa S3 pocket; and (iii) Arg43 from CTI helix α2 forms a salt bridge with FXIIa H1 pocket Asp60A. CTI amino acid substitution R34A negated all inhibitory activity, whereas the G32W, L35A, W22A and R42A/R43A substitutions reduced activity by large degrees of 108-fold, 41-fold, 158-fold, and 100-fold, respectively; the R27A, W37A, W39A and R42A substitutions had no effect. Synthetic peptides spanning CTI residues 20-44 had inhibitory activity that was three-fold to 4000-fold less than that of full-length CTI. Conclusions The data confirm the validity of a canonical model of the FXIIa-CTI interaction, with helix α1 (Trp22), central inhibitory loop (Arg34) and helix α2 (Arg43) of CTI being required for effective binding by contacting the S1, S3 and H1 pockets of FXIIa, respectively.
Essentials Corn Trypsin Inhibitor (CTI) 是凝血因子 XII (FXII) 的选择性抑制剂。CTI-FXIIa 复合物的分子建模表明存在典型的抑制剂结合模式。突变分析揭示了 CTI 的抑制环和 α1 及 α2 螺旋介导了相互作用。这证实 CTI 以典型方式抑制 FXII,并验证了分子模型。
背景 Corn trypsin inhibitor (CTI) 对丝氨酸蛋白酶凝血因子 XII 和胰蛋白酶具有选择性。CTI 被广泛用作特异性抑制血液凝固内在途径而不抑制外在途径的试剂。目的 研究 CTI 抑制 FXII 的分子基础。方法 我们使用其已知晶体结构对激活的 FXII(FXIIa)蛋白酶结构域进行 CTI 的分子对接。通过使用一组重组 CTI 变体进行 FXIIa 酶促活性的底物切割测定来验证相互作用模型,这些变体用于测试其抑制 FXIIa 酶促活性的能力。结果 对接预测:(i)CTI 中心抑制环 P1 Arg34 侧链与 FXIIa S1 口袋 Asp189 侧链形成盐桥;(ii)CTI 螺旋 α1 的 Trp22 与 FXIIa S3 口袋相互作用;和(iii)CTI 螺旋 α2 的 Arg43 与 FXIIa H1 口袋 Asp60A 形成盐桥。CTI 氨基酸取代 R34A 使所有抑制活性都丧失,而 G32W、L35A、W22A 和 R42A/R43A 取代使活性分别降低 108 倍、41 倍、158 倍和 100 倍;R27A、W37A、W39A 和 R42A 取代没有影响。跨越 CTI 残基 20-44 的合成肽具有的抑制活性比全长 CTI 低 3 倍至 4000 倍。结论 数据证实了 FXIIa-CTI 相互作用的典型模型的有效性,其中 CTI 的螺旋 α1(Trp22)、中心抑制环(Arg34)和螺旋 α2(Arg43)分别与 FXIIa 的 S1、S3 和 H1 口袋接触,是有效结合所必需的。